The most significant players in the pathophysiology of AHC are probably mutations related to ATP1A3. Still, environmental factors are believed to trigger or exacerbate episodes in genetically susceptible individuals. This evidence concerns the gene ATP1A3 and alternating hemiplegia of childhood.